Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
AnaptysBio is developing its own wholly owned PD-1 agonist candidate for rheumatoid arthritis, rosnilimab, with data expected in Q1 2025
How it works: TB-500 is a synthetic fragment of Thymosin Beta-4, a protein your body uses to move healing cells to damaged areas and build new blood vessels
Malaysia Glutathione Market Size and Forecast, by Product Type (2025-2032) 7.4.7.2
The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors
Published: July 30, 2025 Media Contact: [email protected]
US$ 25.36
US$ 27.22
US$ 25.77
